Metropolitan Life Insurance Company (MetLife)’s ACV Auctions ACVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,786
Closed -$127K 41
2024
Q1
$127K Sell
6,786
-578
-8% -$9.05K 0.01% 921
2023
Q4
$112K Hold
7,364
0.01% 1019
2023
Q3
$112K Buy
7,364
+387
+6% +$6.29K 0.01% 952
2023
Q2
$120K Buy
6,977
+607
+10% +$9.28K 0.01% 922
2023
Q1
$82.2K Sell
6,370
-720
-10% -$7.87K ﹤0.01% 1104
2022
Q4
$58.2K Hold
7,090
﹤0.01% 1375
2022
Q3
$51K Hold
7,090
﹤0.01% 1452
2022
Q2
$46.4K Buy
+7,090
New +$73K ﹤0.01% 1554

Other funds holding ACVA

Metropolitan Life Insurance Company (MetLife)'s ACVA Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of ACV Auctions (ACVA) in Q2 2024, closing a stake of 6,786 shares — an estimated $127K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ACVA in Q2 2022 and held it in 8 quarters. The position peaked at $127K in Q1 2024. 197 funds tracked by Wall St. Rank hold ACVA as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining ACV Auctions position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 6,786 ACV Auctions shares in Q2 2024, an estimated $127K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in ACV Auctions in Q2 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s ACV Auctions position peaked at $127K in Q1 2024.
  • 197 funds tracked by Wall St. Rank held ACV Auctions as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.